Please login to the form below

Not currently logged in
Email:
Password:

Cystic Fibrosis Buyers' Club

This page shows the latest Cystic Fibrosis Buyers' Club news and features for those working in and with pharma, biotech and healthcare.

BuyersClub wants government support on Orkambi imports

Buyers’ Club wants government support on Orkambi imports

The Cystic Fibrosis Buyers’ Club has asked health secretary Matt Hancock to help patients circumvent Vertex and find alternative ways to gain access to Orkambi – including the import of generic versions ... compulsory licensing) crown use licence,

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    Dialogue with pharma? No thanks. As with the UK’s Cystic Fibrosis Buyers’ Club advocates, T1International doesn’t see dialogue with pharma as being worthwhile – after years of frustration and debates

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis BuyersClub

    to source what could also be life- saving drugs: the Cystic Fibrosis Buyers’ Club. ... Dairmaid McDonald and the Just Treatment team are supporting the Cystic Fibrosis Buyers’ Club to make the goal a reality, and have approached the task with

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...

Infographics